סימוביל 40 מ"ג

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

SIMVASTATIN 40 MG

제공처:

MERCK SHARP & DOHME ISRAEL LTD

ATC 코드:

C10AA01

약제 형태:

TABLETS

관리 경로:

PER OS

Manufactured by:

MERCK SHARP & DOHME B.V, HOLLAND

치료 그룹:

SIMVASTATIN

치료 징후:

Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simovil is indicated to: Reduce the risk of total mortality by reducing coronary death; Reduce the risk of non-fatal myocardial infarction; Reduce the risk for undergoing myocardial revascularization procedures; Reduce the risk of stroke and transient ischemic attacks (TIA). Hyperlipidemia: Simovil is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simovil therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hypertriglycerid

승인 날짜:

2013-01-01